SHH · 688105.SS
Nanjing Vazyme Biotech Co., Ltd.
CN¥22.58+CN¥0.66 (+3.01%)
Nanjing Vazyme Biotech Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 22.57% below the high.
Loading market information…
SHH · 688639.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Anhui Huaheng Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Anhui Huaheng Biotechnology Co., Ltd.’s forward annual dividend is CN¥0.16 per share, paid annual. The forward yield is 1.09% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Anhui Huaheng Biotechnology Co., Ltd.’s next earnings report is currently expected on Apr 28, 2027, with estimated earnings per share of CN¥0.38. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Anhui Huaheng Biotechnology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Anhui Huaheng Biotechnology Co., Ltd. specializes in the research, manufacturing, and international distribution of amino acids and various organic acids. The company's product range encompasses L-alanine, DL-alanine, beta-alanine, and D-alanine, as well as L-aspartic, DL-aspartic, D-aspartic acids, and L-aspartate salt. Additionally, it provides an array of other amino acids and arbutin products. These ingredients are widely utilized in pharmaceuticals, healthcare goods, food and food additives, daily personal care items, and other diverse industrial applications. Founded in Hefei, China, in 2005, the company operated as Anhui Huaheng Biological Engineering Co., Ltd. until its name officially changed to Anhui Huaheng Biotechnology Co., Ltd. in November 2013.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥704.38M |
| Q2 2025 | Aug 27, 2025 | CN¥0.36-10.09% vs estimate | CN¥802.00M+0.25% vs estimate |
|---|
| Q1 2025 | Apr 22, 2025 | CN¥0.08-71.5% vs estimate | CN¥638.91M+42.25% vs estimate |
|---|
| Q1 2025 | Apr 22, 2025 | CN¥0.20-26.44% vs estimate | CN¥687.06M+52.97% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥22.58+CN¥0.66 (+3.01%)
Nanjing Vazyme Biotech Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 22.57% below the high.
CN¥4.93-CN¥0.12 (-2.38%)
Chengzhi Shareholding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.59% below the high.
CN¥14.98+CN¥1.36 (+9.99%)
Guilin Sanjin Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.89% below the high.
CN¥18.26+CN¥0.11 (+0.61%)
Aurisco Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.68% below the high.
CN¥5.18-CN¥0.09 (-1.71%)
Daan Gene Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.83% below the high.
CN¥41.05-CN¥0.72 (-1.72%)
Chengdu Easton Biopharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.99% below the high.
CN¥47.84+CN¥0.18 (+0.38%)
Chengdu Kanghua Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.69% below the high.
CN¥7.27+CN¥0.06 (+0.83%)
Zhejiang Ausun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.75% below the high.
